Loading...
A

Augmedix Inc
NASDAQ:AUGX

Watchlist Manager
Augmedix Inc
NASDAQ:AUGX
Watchlist
Price: 1.12 USD Market Closed
Updated: Dec 10, 2022

Intrinsic Value

The intrinsic value of one AUGX stock under the Base Case scenario is 2.58 USD. Compared to the current market price of 1.12 USD, Augmedix Inc is Undervalued by 57%.

The Intrinsic Value is calculated as the average of the two valuation methods:

AUGX Intrinsic Value
Base Case
2.58 USD
Undervaluation 57%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Fundamental Analysis

AUGX Profitability Score
Profitability Due Diligence

Augmedix Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
Negative Net Income
46/100
Profitability
Score

Augmedix Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

AUGX Solvency Score
Solvency Due Diligence

Augmedix Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Low Altman Z-Score
High D/E
Long-Term Liabilities
32/100
Solvency
Score

Augmedix Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
45%
Gross Margin
-76%
Operating Margin
-85%
Net Margin
-52%
FCF Margin
8 482%
ROE
-331%
ROIC
Other

AUGX Capital Structure
Augmedix Inc

Market Capitalization 41.9M USD
Total Debt 13.2M USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 26.3M USD
Short-Term Investments 0 USD
Enterprise Value 28.8M USD

Wall St
Price Targets

AUGX Price Targets Summary
Augmedix Inc

Wall Street analysts forecast AUGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUGX is 4.97 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.

Lowest
Price Target
4.04 USD
261% Upside
Average
Price Target
4.97 USD
344% Upside
Highest
Price Target
6.3 USD
463% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

AUGX Competitors
Augmedix Inc

AUGX Suppliers & Customers
Augmedix Inc

Augmedix Inc has 1 key suppliers from 1 countries and 1 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Media industry.

United States of America
1
Suppliers Map

Augmedix Inc has 3 key customers from 1 countries and 1 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.

Ownership

AUGX Insider Trading
Buy and sell transactions by insiders

Augmedix Inc insiders have bought more shares than they have sold in the past 12 months.

During the last 12 months Augmedix Inc insiders bought 110k USD , and sold 103k USD worth of shares. The last transaction was made on Dec 10, 2022 by Mckesson Ventures, Llc (10 percent owner), who sold 4.3k USD worth of AUGX shares.

Sold
0-3
months
103k USD
1
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
3
110k USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
103k USD
N/A
-103k
6 Months
103k USD
N/A
-103k
9 Months
103k USD
110k USD
7.1k
12 Months
103k USD
110k USD
7.1k
Purchases
24
Sales
13
Why is insider trading important?

Shareholder Return

AUGX Price
Augmedix Inc

1M 1M
-22%
6M 6M
-45%
1Y 1Y
-69%
3Y 3Y
-78%
5Y 5Y
-78%
Annual Price Range
1.12
52w Low
1.12
52w High
3.64
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -85%
Shares Statistics
Market Capitalization 41.9M USD
Shares Outstanding 37 421 200
Percentage of Shares Shorted 0.64%

Company Profile

Augmedix Inc

Country

United States of America

Industry

Health Care

Market Cap

41.9M USD

Dividend Yield

0%

Description

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists (MDS). Augmedix provides service from approximately nine MDS operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.

Contact

CALIFORNIA
San Francisco
111 Sutter Street, Suite 1300, Suite Ll
+15619892208.0
https://augmedix.com/

IPO

2021-03-04

Employees

706

Officers

Pres, CEO, Sec. & Director
Mr. Emmanuel Krakaris
Founder, Chief Strategy Officer & Director
Mr. Ian Shakil
Chief Operating Officer
Ms. Sandra Breber
Chief Technology Officer
Mr. Saurav Chatterjee Ph.D.
Chief Financial Officer
Mr. Paul Louis Ginocchio
Head of Legal & Compliance
Todd Holvick
Show More
Head of People
Lia Wallick
Chief Medical Officer
Dr. Davin Lundquist M.D.
Chief Revenue Officer
Mr. Jonathan Hawkins
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one AUGX stock?

The intrinsic value of one AUGX stock under the Base Case scenario is 2.58 USD.

Is AUGX stock undervalued or overvalued?

Compared to the current market price of 1.12 USD, Augmedix Inc is Undervalued by 57%.